Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 115, Issue 4, 2001, Pages 831-844

  Vuillier, Françoise ^a   Maloum, Karim ^b   Thomas, Elaine K ^c   Jouanne, Colette ^a   Dighiero, Guillaume ^a   Scott Algara, Daniel ^a  

^a INSTITUT PASTEUR   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c AMGEN INC   (United States)

Author keywords

Chronic lymphocytic leukaemia; Cytokine; Dendritic cell; Immunotherapy

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 4;

AGED; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CD40 LIGAND; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY, ACTIVE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-4; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MONOCYTES;

EID: 0035669305     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03223.x     Document Type: Article

References (78)

1. Immunotherapy with monoclonal anti-idiotypic antibodies: Tumour reduction and lymphokine production
2. Dendritic cells and the control of immunity
3. Immunobiology of dendritic cells
4. Update on the biology of chronic lymphocytic leukemia
5. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
6. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
7. Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation
8. Human tumor antigens recognized by T lymphocytes
9. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor
10. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells
11. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor
12. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: Stimulation of allogeneic versus autologous T cells generates different types of effector cells
13. Activation of human dendritic cells through CD40 cross-linking
14. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
15. Origin, maturation and antigen presenting function of dendritic cells
16. Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer
17. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: Implications for immunotherapy
18. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
19. Effect of interleukin-10 on dendritic cell maturation and function
20. When and how to treat chronic lymphocytic leukemia
21. B-cell chronic lymphocytic leukemia: Present status and future directions
22. Chlorambucil in indolent chronic lymphocytic leukemia
23. Distinct subsets of dendritic cells resembling dermal DC can be generated in vitro from monocytes, in the presence of different serum supplements
24. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance
25. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
26. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: Correlation with phenotypic characteristics and outcome
27. Control of T lymphocyte signal transduction through clonal anergy
28. Dendritic cells in cancer immunotherapy
29. Immune regulation by CD40 and its ligand GP39
30. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo
31. The role of CD40 ligand in costimulation and T-cell activation
32. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells
33. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype
34. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
35. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: Potential for cellular vaccine development
36. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: A role for IL-15 in attraction of T cells
37. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells
38. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice
39. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation
40. IL-15 stimulates the expansion of AIDS virus-specific CTL
41. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma
42. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
43. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells
44. Mechanisms of antigen uptake for presentation
45. Induction of Th2 cell differentiation in the primary immune response: Dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4
46. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells
47. Direct evidence to support the immunosurveillance concept in a human regressive melanoma
48. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
49. Generation of monocyte-derived dendritic cells from patients with renal cell cancer: Modulation of their functional properties after therapy with biological response modifiers (IFN-alpha plus IL-2 and IL-12)
50. High gradient magnetic cell separation with MACS
51. Immunotherapy of cancer using dendritic cells
52. Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells
53. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment
54. The role of CD4(+) T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8(+) T cell responses
55. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes
56. Functional and phenotypic characteristics of dendritic cells generated in human plasma supplemented medium
57. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma - A feasibility study
58. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia
59. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells
60. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
61. Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells
62. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit
63. High-level IL-12 production by human dendritic cells requires two signals
64. DNA vaccines against lymphoma: Promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C
65. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
66. Induction of tolerance by IL-10-treated dendritic cells
67. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
68. Comparison of normal and CLL lymphocyte surface Ig determinants using peroxidase-labeled antibodies. I. Detection and quantitation of light chain determinants
69. Dendritic cell vaccines for cancer immunotherapy
70. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: Immunological and clinical aspects
71. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders
72. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
73. Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies
74. Functions of CD40 on B cells, dendritic cells and other cells
75. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction
76. Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma
77. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells
78. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b)